130. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons MS, Tashkin DP. 1998. Airway inflammation in young marijuana and tobacco smokers. American Journal of Respiratory and Critical Care Medicine 157:1-9.
131. Roth MD, Kleerup EC, Arora A, Barsky SH, Tashkin DP. 1996. Endobronchial injury in young tobacco and marijuana smokers as evaluated by visual, pathologic and molecular criteria. American Review of Respiratory and Critical Care Medicine 153 (part 2):100A.
132. SAMHSA (Substance Abuse and Mental Health Services Administration). 1998. National Household Survey on Drug Abuse: Population Estimates 1997. DHHS Pub. No. (SMA) 98-3250. Rockville, MD: SAMHSA, Office of Applied Studies.
133. Scheier LM, Bovtin GJ. 1996. Cognitive effects of marijuana. Journal of the American Medical Association 275:JAMA Letters.
134. Schneier FR, Siris SG. 1987. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. Journal of Nervous and Mental Disease 175:641652.
135. Schuel H, Berkery D, Schuel R, Chang MC, Zimmerman AM, Zimmerman S. 1991. Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. I. Inhibition of the acrosome reaction induced by egg jelly. Molecular Reproduction and Development 29:51-59.
136. Schuel H, Chang MC, Berkery D, Schuel R, Zimmerman AM, Zimmerman S. 1991. Cannabinoids inhibit fertilization in sea urchins by reducing the fertilizing capacity of sperm. Pharmacology, Biochemistry, and Behavior 40:609-615.
137. Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. 1994. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor, agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proceedings of the National Academy of Sciences 91:7678-7682.
138. Sidney S, Beck JE, Tekawa IS, Quesenberry CP Jr, Friedman GD. 1997a. Marijuana use and mortality. American Journal of Public Health 87:585-590.
139. Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. 1997b. Marijuana use and cancer incidence (California, United States). Cancer Cause and Control 8:722-728.
140. Solowij N. 1995. Do cognitive impairments recover following cessation of cannabis use? Life Sciences 56:2119-2126.
141. Sridhar JS, Raub WA, Weatherby NL, et al. 1994. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. Journal of Psychoactive Drugs 26:285-288.
142. Stenchever MA, Kunysz TJ, Allen MA. 1974. Chromosome breakage in users of marijuana. American Journal of Gynecology 118:106-113.
143. Stephens RS, Roffman RA, Simpson EE. 1993. Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology 61:1100-1104.
144. Tanda G, Pontieri FE, Di Chiara G. 1997. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common 1l opioid receptor mechanism. Science 276:2048-2049.
145. Tart CT. 1971. On Being Stoned: A Psychological Study of Marijuana Intoxication. Palo Alto, CA: Science and Behavior Books.
146. Tashkin DP, Coulson AH, Clark VA, Simmons M, Bourque LB, Duann S, Spivey GH, Gong H. 1987. Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. American Review of Respiratory Disease 135:209-216.
147. Tashkin DP, Simmons MS, Sherrill DL, Coulson AH. 1997. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. American Journal of Respiratory and Critical Care Medicine 155:141-148.